Bucelipase alfa
- Generic Name
- Bucelipase alfa
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9026-00-0
- Unique Ingredient Identifier
- 3C617U1K19
- Background
Bucelipase alfa is under investigation in clinical trial NCT00743483 (Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency).
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 15
- Registration Number
- NCT00743483
- Locations
- 🇳🇱
Erasmus Medical Center, Rotterdam, Netherlands
🇵🇱Specjalistyczny Zespól Opieki Zdrowotnej nad Matka i Dzieckiem w Gdansku, Gdansk, Poland
🇵🇱Uniwersytet Medyczny im. K. Marcinkowskiego, Poznan, Poland
Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Pasteurized Breast Milk for Preterm Infants
- Conditions
- Interventions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2014-11-02
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 32
- Registration Number
- NCT00659243
- Locations
- 🇫🇷
Hopital de la Croix Rousse, Lyon, France
🇫🇷Maternité A. Pinard, Néonatologie, Nancy, France
🇫🇷Hopital Saint Vincent de Paul, Paris, France
Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants
- Conditions
- Interventions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2014-11-02
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 33
- Registration Number
- NCT00658905
- Locations
- 🇮🇹
Clinical Pediatrica-Neonatologia, Policlinico Gemelli, Universita Cattolica, Rome, Italy
🇮🇹Azienda Ospedaliera "Ospedale Policlinico Consorziale",U.O Neonatologia e Terapia Intensiva Neonatale, Bari, Italy
🇮🇹Presidio Ospedaliero di Alta Specializzazione G.Salesi Azienda Ospedaliero Universitaria Ospedali Riuniti "Umberto I-G.M.Lancisi -G.Salesi, Ancona, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.